PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23419354-1	2013	The aim of the present study was to clarify the involvement of P-glycoprotein (P-gp) or organic anion transporting polypeptide (Oatp) 1a5 in the pharmacokinetics of nadolol (NDL), a non-metabolized hydrophilic beta-adrenoceptor blocker, in rats.	Nadolol	165-172	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	63-77	
23419354-1	2013	The aim of the present study was to clarify the involvement of P-glycoprotein (P-gp) or organic anion transporting polypeptide (Oatp) 1a5 in the pharmacokinetics of nadolol (NDL), a non-metabolized hydrophilic beta-adrenoceptor blocker, in rats.	Nadolol	165-172	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	79-83	
23419354-2	2013	Pretreatment with itraconazole (ICZ, P-gp inhibitor, 50 mg/kg) for 30 min before oral administration of NDL (10 mg/kg) significantly increased the area under the plasma concentration-time curve (AUC0- )of NDL by 1.7-fold compared with control.	Nadolol	104-107	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	37-41	
23419354-2	2013	Pretreatment with itraconazole (ICZ, P-gp inhibitor, 50 mg/kg) for 30 min before oral administration of NDL (10 mg/kg) significantly increased the area under the plasma concentration-time curve (AUC0- )of NDL by 1.7-fold compared with control.	Nadolol	205-208	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	37-41